论文部分内容阅读
本文采用随机双盲对照试验研究,试验组与对照组各100例。试验组于产后48 h用缩宫素鼻喷雾剂对产妇一侧鼻孔喷入2喷。每隔2 h喷一次,共3次。对照组用安慰剂代替缩宫素鼻喷雾剂,方法同前。分别于每次用药后5 min和停药后24h观察总乳汁量、吸空时间、乳腺管通畅度及乳房结节等。以综合疗效评分为疗效判断标准。结果:试验组显效率41%,有效率37%,总有效率78%,无效率22%;对照组显效率6%,有效率23%,总有效率29%,无效率71%。经统计学处理两组疗效有显著差异(P<0.01)。该药有明显促进乳腺管通畅作用,提高乳汁排出量和完全母乳喂养率,且未见药物不良反应,安全可靠。
In this paper, a randomized double-blind controlled trial study, the experimental group and the control group of 100 cases. The experimental group 48 h postpartum with oxytocin nasal spray on the maternal side of the nose spray 2 spray. Spray every 2 h, a total of 3 times. The control group with placebo instead of oxytocin nasal spray, the same way. The total milk volume, suction time, the degree of breast duct patency and breast nodules were observed 5 min after each treatment and 24h after stopping. A comprehensive evaluation of efficacy as a criterion for efficacy. Results: In the experimental group, the effective rate was 41%, the effective rate was 37%, the total effective rate was 78% and the ineffective rate was 22%. In the control group, the effective rate was 6%, the effective rate was 23%, the total effective rate was 29%, and the ineffective rate was 71%. The statistical difference between the two groups was significant (P <0.01). The drug has a clear role in promoting patency of the mammary duct, increase milk output and complete breastfeeding rate, and no adverse drug reactions, safe and reliable.